Fwelo Pierre, Afolayan Oladipo, Nwosu Kenechukwu O S, Ojaruega Akpevwe A, Ahaiwe Onyekachi, Olateju Olajumoke A, Ezeigwe Ogochukwu Juliet, Adekunle Toluwani E, Bangolo Ayrton
UTHealth School of Public Health, Department of Epidemiology, Human Genetics & Environmental Sciences, Houston, TX, USA.
UTHealth School of Public Health, Department of Biostatistics, Houston, TX, USA.
Surg Oncol. 2023 Oct;50:101983. doi: 10.1016/j.suronc.2023.101983. Epub 2023 Aug 18.
This study examined the associations of socioeconomic status (SES), race/ethnicity, surgery type, and treatment delays with mortality among colon cancer patients. In addition, the study also quantifies the extent to which clinical and SES factors' variations explain the racial/ethnic differences in overall survival.
We studied 111,789 adult patients ≥45 years old who were diagnosed with colon cancer between 2010 and 2017, identified from the Surveillance, Epidemiology, and End Results (SEER) database. We performed logistic regression models to examine the association of SES and race/ethnicity with surgery type and first course of treatment delays. We also performed mediation analysis to quantify the extent to which treatment, sociodemographic and clinicopathologic factors mediated racial/ethnic differences in survival.
Non-Hispanic (NH) Blacks [adjusted Odds Ratio (aOR) = 1.19, 95% CI:1.13-1.25] were significantly more likely to undergo subtotal colectomy and to experience treatment delays [aOR = 1.39, 95% CI: 1.31-1.48] compared to NH Whites. Hispanics [aOR = 1.59, 95% CI: 1.49-1.69] were more likely to experience treatment delays than NH Whites. Delayed first course of treatment explained 23.56% and 56.73% of the lower survival among NH Blacks and Hispanics, respectively, compared to their NH White counterparts.
Race/ethnicity is significantly associated with the surgery type performed and the first course of treatment delays. Variations in treatment, SES, and clinicopathological factors significantly explained racial disparities in overall mortality. These disparities highlight the need for multidisciplinary interventions to address the treatment and social factors perpetuating racial disparities in colon cancer mortality.
本研究探讨了社会经济地位(SES)、种族/民族、手术类型和治疗延迟与结肠癌患者死亡率之间的关联。此外,该研究还量化了临床和SES因素的差异在多大程度上解释了总体生存中的种族/民族差异。
我们研究了2010年至2017年间从监测、流行病学和最终结果(SEER)数据库中识别出的111789例年龄≥45岁的成年结肠癌患者。我们进行了逻辑回归模型,以检验SES和种族/民族与手术类型和首次治疗延迟之间的关联。我们还进行了中介分析,以量化治疗、社会人口学和临床病理因素在多大程度上介导了生存中的种族/民族差异。
与非西班牙裔白人相比,非西班牙裔黑人[调整后的优势比(aOR)=1.19,95%置信区间:1.13-1.25]接受次全结肠切除术和经历治疗延迟的可能性显著更高[aOR=1.39,95%置信区间:1.31-1.48]。西班牙裔[aOR=1.59,95%置信区间:1.49-1.69]比非西班牙裔白人更有可能经历治疗延迟。与非西班牙裔白人相比,首次治疗延迟分别解释了非西班牙裔黑人和西班牙裔较低生存率的23.56%和56.73%。
种族/民族与所进行的手术类型和首次治疗延迟显著相关。治疗、SES和临床病理因素的差异显著解释了总体死亡率中的种族差异。这些差异凸显了需要多学科干预来解决导致结肠癌死亡率种族差异持续存在的治疗和社会因素。